DelMar Pharma Revenue, Profits - DMPI Annual Income Statement

Add to My Stocks
$0.8 $0.02 (2.56%) DMPI stock closing price Sep 21, 2018 (Closing)

DMPI stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the DelMar Pharma stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement for DMPI which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Revenue for year 2017 is $- and has decreased from $- year on year as is evident when you compare the latest figures in the latest DelMar Pharma profit and loss statement with those of the prior corresponding period. Also see DelMar Pharma assets and DelMar Pharma free cash flow for a complete valuation of DMPI stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jul - Jun20172016201520142013201220112010
DelMar Pharma Revenues or Net Sales
--------
Cost Of Goods Sold (COGS)--------
DelMar Pharma Gross Profit
--------
Research & Development Expense5M3.36M2.55M2.11M----
Selling General & Admin Expense3.31M2.85M2.16M3.13M1.65M---
Income Before Depreciation Depletion Amortization-8.32M-6.21M-4.72M-5.25M-2.23M-0.01M-0.03M-0.01M
Depreciation Depletion Amortization--------
Non Operating Income--2.65M-0.06M8.39M-4.57M---
Interest Expense--------
DelMar Pharma Pretax Income
-8.08M-8.86M-4.79M3.12M-6.81M-0.01M-0.03M-0.01M
Provision for Income Taxes--------
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-8.08M-8.86M-4.79M3.12M-6.81M-0.01M-0.03M-0.01M
Extraordinary Items & Discontinued Operations--------
DelMar Pharma Profit/ Loss (Net Income)
-8.08M-8.86M-4.79M3.12M-6.81M-0.01M-0.03M-0.01M
Average Shares used to compute Diluted EPS12.05M10.95M9.52M9.77M----
Average Shares used to compute Basic EPS12.05M10.95M9.52M7.99M----
Income Before Nonrecurring Items-8.08M-6.23M-4.8M3.13M----
Income from Nonrecurring Items--2.64M------
DelMar Pharma Earnings Per Share Basic Net
-0.74-0.81-0.520.40-1.22---
DelMar Pharma Earnings Per Share Diluted Net
-0.74-0.81-0.520.00----
EPS Diluted Before Nonrecurring Items-0.74-0.57-0.520.00----
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on DelMar Pharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that DMPI stock has a topline or revenue of $- for 2017 as per this DelMar Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-8.08M for DMPI stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the DMPI income statement, one can check the DelMar Pharma historical stock prices to check how the price has moved with time.

DelMar Pharma Income Statement - Key Financial Ratios